Panitumumab Use in Metastatic Colorectal Cancer and Patterns of KRAS Testing: Results from a Europe-Wide Physician Survey and Medical Records Review

BACKGROUND: From 2008–2013, the European indication for panitumumab required that patients’ tumor KRAS exon 2 mutation status was known prior to starting treatment. To evaluate physician awareness of panitumumab prescribing information and how physicians prescribe panitumumab in patients with metast...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:PLoS One
Egile Nagusiak: Trojan, Jörg, Mineur, Laurent, Tomášek, Jiří, Rouleau, Etienne, Fabian, Pavel, de Maglio, Giovanna, García-Alfonso, Pilar, Aprile, Giuseppe, Taylor, Aliki, Kafatos, George, Downey, Gerald, Terwey, Jan-Henrik, van Krieken, J. Han
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Public Library of Science 2015
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4619650/
https://ncbi.nlm.nih.gov/pubmed/26491871
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0140717
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak